ǂ «A stable trimeric influenza hemagglutinin stem as a broadly
protective immunogen» by Impagliazzo et al. published in Science on Monday 24th August.
Not exact matches
«We'd like to synthesize vaccine
immunogens [proteins that trigger antibody production] that can elicit the same types of broadly
protective antibodies in people,» says Dr. Chandran.
A major goal of HIV - 1 vaccine development is to identify
immunogens capable of inducing
protective titers of broadly neutralizing antibodies (bNAbs) against circulating, neutralization - resistant (tier 2) viruses.